These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 16390353

  • 1. Effect of rifampicin on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Laitila J, Neuvonen PJ.
    Br J Clin Pharmacol; 2006 Jan; 61(1):70-8. PubMed ID: 16390353
    [Abstract] [Full Text] [Related]

  • 2. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ.
    Clin Pharmacol Ther; 2005 May; 77(5):404-14. PubMed ID: 15900286
    [Abstract] [Full Text] [Related]

  • 3. Trimethoprim and the CYP2C8*3 allele have opposite effects on the pharmacokinetics of pioglitazone.
    Tornio A, Niemi M, Neuvonen PJ, Backman JT.
    Drug Metab Dispos; 2008 Jan; 36(1):73-80. PubMed ID: 17913794
    [Abstract] [Full Text] [Related]

  • 4. Effects of trimethoprim and rifampin on the pharmacokinetics of the cytochrome P450 2C8 substrate rosiglitazone.
    Niemi M, Backman JT, Neuvonen PJ.
    Clin Pharmacol Ther; 2004 Sep; 76(3):239-49. PubMed ID: 15371985
    [Abstract] [Full Text] [Related]

  • 5. Pioglitazone, an in vitro inhibitor of CYP2C8 and CYP3A4, does not increase the plasma concentrations of the CYP2C8 and CYP3A4 substrate repaglinide.
    Kajosaari LI, Jaakkola T, Neuvonen PJ, Backman JT.
    Eur J Clin Pharmacol; 2006 Mar; 62(3):217-23. PubMed ID: 16447051
    [Abstract] [Full Text] [Related]

  • 6. Clopidogrel Markedly Increases Plasma Concentrations of CYP2C8 Substrate Pioglitazone.
    Itkonen MK, Tornio A, Neuvonen M, Neuvonen PJ, Niemi M, Backman JT.
    Drug Metab Dispos; 2016 Aug; 44(8):1364-71. PubMed ID: 27260150
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The pharmacokinetics of pioglitazone in Thai healthy subjects.
    Wittayalertpanya S, Chompootaweep S, Thaworn N.
    J Med Assoc Thai; 2006 Dec; 89(12):2116-22. PubMed ID: 17214065
    [Abstract] [Full Text] [Related]

  • 10. Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.
    Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV.
    J Clin Pharmacol; 2005 Oct; 45(10):1137-44. PubMed ID: 16172178
    [Abstract] [Full Text] [Related]

  • 11. Effect of rifampin on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY, Kim KA, Kang MH, Kim SL, Shin JG.
    Clin Pharmacol Ther; 2004 Mar; 75(3):157-62. PubMed ID: 15001966
    [Abstract] [Full Text] [Related]

  • 12. Effects of a concomitant single oral dose of rifampicin on the pharmacokinetics of pravastatin in a two-phase, randomized, single-blind, placebo-controlled, crossover study in healthy Chinese male subjects.
    Deng S, Chen XP, Cao D, Yin T, Dai ZY, Luo J, Tang L, Li YJ.
    Clin Ther; 2009 Jun; 31(6):1256-63. PubMed ID: 19695392
    [Abstract] [Full Text] [Related]

  • 13. Montelukast and zafirlukast do not affect the pharmacokinetics of the CYP2C8 substrate pioglitazone.
    Jaakkola T, Backman JT, Neuvonen M, Niemi M, Neuvonen PJ.
    Eur J Clin Pharmacol; 2006 Jul; 62(7):503-9. PubMed ID: 16670899
    [Abstract] [Full Text] [Related]

  • 14. No pharmacokinetic interaction between ipragliflozin and sitagliptin, pioglitazone, or glimepiride in healthy subjects.
    Smulders RA, Zhang W, Veltkamp SA, van Dijk J, Krauwinkel WJ, Keirns J, Kadokura T.
    Diabetes Obes Metab; 2012 Oct; 14(10):937-43. PubMed ID: 22587345
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects.
    Bolton AE, Peng B, Hubert M, Krebs-Brown A, Capdeville R, Keller U, Seiberling M.
    Cancer Chemother Pharmacol; 2004 Feb; 53(2):102-6. PubMed ID: 14605865
    [Abstract] [Full Text] [Related]

  • 17. Truncated areas under the curve in the assessment of pioglitazone bioequivalence. Data from a single-center, single-dose, randomized, open-label, 2-way cross-over bioequivalence study of two formulations of pioglitazone 45 mg tablets under fasting conditions.
    Almeida S, Filipe A, Neves R, Pinho C, Pedroso P, Castillo A, Trabelsi F.
    Arzneimittelforschung; 2011 Feb; 61(1):32-9. PubMed ID: 21355444
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of pioglitazone in lean and obese cats.
    Clark MH, Hoenig M, Ferguson DC, Dirikolu L.
    J Vet Pharmacol Ther; 2012 Oct; 35(5):428-36. PubMed ID: 22612529
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of ketoconazole on the pharmacokinetics of rosiglitazone in healthy subjects.
    Park JY, Kim KA, Shin JG, Lee KY.
    Br J Clin Pharmacol; 2004 Oct; 58(4):397-402. PubMed ID: 15373932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.